On June 24, BioHive held their inaugural Women’s event sponsored by BD, BioMerieux, e4H Architects, Health Catalyst, Known Medicine, MarshMcLennan, Recursion, Seek Labs and JLL Realty. With 180 registrants from 54 companies, attendees packed over 200 STEM Kits in partnership with Utah STEM Action Center for elementary and middle school students, listened to a panel […]
LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter ended March 31, 2022. Recent Highlights (including […]
Governor Cox has invited Utah’s life sciences industry to engage in a bold initiative called the “One Utah Health Collaborative.” Cox understands the importance of our industry to the healthcare system and it’s appropriate that we be at the table. Below we provide more detailed information about the initiative and opportunities to participate. Background Last […]
Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based, nonprofit healthcare system, which leverages genomic testing and data analytics to advance research intended to improve outcomes for cancer patients. Intermountain Healthcare is leveraging Tempus’ solid tumor/normal genomic test, xT, to generate whole transcriptomic data on existing […]
AMERICAN FORK, Utah, June 22, 2022 /PRNewswire/ — KT Tape®, the leader in drug-free pain relief products, today announced that after a national executive search, the company’s board of directors has appointed Jessica Klodnicki as its new chief executive officer. Klodnicki is a recognized transformative leader in the outdoor brands and consumer products industry with […]
IONIQ Sciences unveiled its next-generation platform called LUNA3™ for early-stage cancer detection. LUNA3 is designed to accelerate the transition of cancer testing from the hospital and doctor’s office into pharmacies and ultimately into consumers’ homes. […]
Springville, Utah June 21, 2022—ATL Technology (“ATL”), a joint development manufacturing partner to top medical device firms, announced the acquisition of BioVision Technologies, LLC (“BioVision”). ATL has a proven track record of developing custom interconnect solutions for energy driven medical devices. Using an engineer-to-engineer approach over the last two decades, the company has been expanding […]
Members of the Utah Rare Disease Advisory Council (RDAC) on Monday participated in the Utah Juneteenth Holiday Health & Wellness Expo, National Sickle Cell Day, held at the Gallivan Center, in Salt Lake City, Utah. Toya Jules and Matt Pearl, RDAC members and rare disease patients, exhibited at the day long event. “The RDAC felt it was important […]
Utah’s life sciences industry left its mark on this week’s 2022 BIO International Convention at the San Diego Convention Center (June 13-16). Curavit, Curza, Recursion, Cytiva and Thermo Fisher showcased their companies at the convention that featured more than 3,000 companies and 100-plus panel sessions over four days. Topics included cell and gene therapies, next-gen […]
MANCHESTER, England & SALT LAKE CITY–(BUSINESS WIRE)–The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announced today that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH). The BACF was […]
CAMBRIDGE, Mass., June 8, 2022 /PRNewswire/ — Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food Drug and Administration (FDA) granted Orphan Drug Designation for TP-3654, the company’s proprietary investigational oral inhibitor of PIM kinases, for the treatment of myelofibrosis. “This designation is an important milestone in […]
CHICAGO, June 06, 2022 — Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today detailed the results of its Phase 2 clinical trial (Study RM-202) of rivoceranib, an orally administered tyrosine kinase inhibitor (TKI), in patients with progressive recurrent […]